Actively Recruiting
Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Led by Galmed Pharmaceuticals Ltd · Updated on 2026-03-17
32
Participants Needed
1
Research Sites
20 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.
CONDITIONS
Official Title
Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female healthy volunteers with body mass index (BMI) in the range of 18-30.9 kg/ m2 inclusive
- Deemed healthy on the basis of clinical history, physical examination, ECG, vital signs, and laboratory tests of blood and urine
- Agree to follow-up the contraception requirements of the trial
- Able to give fully informed written consent
You will not qualify if you...
- Females of reproductive potential who are pregnant or lactating
- Positive tests for hepatitis B, C or HIV
- History of severe adverse reaction to any drug
- Known sensitivity to drug medication
- Drug or alcohol abuse
- Smoking in the 3 months prior the study
- Clinically relevant abnormal lab results, medical history or concurrent medical condition
- Evidence of acute or chronic disease
- Inability to adhere to study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hammersmith Medicines Research (HMR)
London, United Kingdom, NW10 7EW
Actively Recruiting
Research Team
Y
Yossi Gilgun-Sherki, PhD, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here